BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 21723358)

  • 1. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.
    Castilla J; Moran J; Martinez-Artola V; Reina G; Martinez-Baz I; Garcia Cenoz M; Alvarez N; Irisarri F; Arriazu M; Elia F; Salcedo E
    Euro Surveill; 2011 Feb; 16(7):. PubMed ID: 21345321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
    Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
    Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.
    Castilla J; Martínez-Artola V; Salcedo E; Martínez-Baz I; Cenoz MG; Guevara M; Alvarez N; Irisarri F; Morán J; Barricarte A;
    Vaccine; 2012 Jan; 30(2):195-200. PubMed ID: 22100636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.
    Hardelid P; Fleming DM; Andrews N; Barley M; Durnall H; Mangtani P; Pebody R
    Vaccine; 2012 Feb; 30(7):1371-8. PubMed ID: 22178524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.
    Puig-Barberà J; Arnedo-Pena A; Pardo-Serrano F; Tirado-Balaguer MD; Pérez-Vilar S; Silvestre-Silvestre E; Calvo-Mas C; Safont-Adsuara L; Ruiz-García M;
    Vaccine; 2010 Nov; 28(47):7460-7. PubMed ID: 20875486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A; Berggren I; Insulander M; de Jong B; Svenungsson B
    Clin Infect Dis; 2011 May; 52(10):1203-11. PubMed ID: 21507917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years.
    Hadler JL; Baker TN; Papadouka V; France AM; Zimmerman C; Livingston KA; Zucker JR
    J Infect Dis; 2012 Jul; 206(1):49-55. PubMed ID: 22551808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.
    Rodríguez-Rieiro C; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; Iniesta-Fornies D; Barranco-Ordoñez D; Cameno-Heras M; Jiménez-García R
    Vaccine; 2011 Feb; 29(6):1332-8. PubMed ID: 21182996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.
    Cheng AC; Kotsimbos T; Kelly HA; Irving LB; Bowler SD; Brown SG; Holmes M; Jenkins CR; Thompson P; Simpson G; Wood-Baker R; Senanayake SN; Brady SJ; Paterson DL; Wark PA; Upham JW; Korman TM; Dwyer DE; Waterer GW; Kelly PM
    Vaccine; 2011 Oct; 29(43):7320-5. PubMed ID: 21810450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.
    Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.
    Gilca R; Deceuninck G; De Serres G; Boulianne N; Sauvageau C; Quach C; Boucher FD; Skowronski DM
    Pediatrics; 2011 Nov; 128(5):e1084-91. PubMed ID: 21987710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.